HistoryPedia - Внесок користувача [uk]

Lu W, Nechuta SJ, Cadmus-Bertram L, Patterson RE, Sternfeld B et

2018-01-15T16:50:34Z

Twig24helen:

J Cancer Surviv. 2010;4(two):119?7. Emery CF, Yang HC, Frierson GM, Peterson LJ, Suh S. Determinants of physical activity among women treated for breast cancer inside a 5-year longitudinal follow-up investigation. Psychooncology. 2009;18(4):377?6. Silber JH, [https://dx.doi.org/10.3121/cmr.2012.1100.ps1-07 title= cmr.2012.1100.ps1-07] Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, Wang M, Niknam BA, Ludwig JM, Wang W et al. Characteristics linked with differences in survival amongst black and white females with breast cancer. JAMA. 2013;310(4):389?7. Paxton RJ, Phillips KL, Jones LA, Chang S, Taylor WC, Courneya KS, Pierce JP. Associations among physical activity, physique mass index, and health-related high quality of life by race/[http://hs21.cn/comment/html/?190745.html E logistic regression evaluation, age, income, privacy, family members help even though working with] ethnicity inside a diverse sample of breast cancer survivors. Cancer. 2012;118(16):4024?1. Brawley OW. Wellness disparities in breast cancer. Obstet Gynecol Clin North Am. 2013;40(three):513?3. O'Neill SC, DeFrank JT, Vegella P, Richman AR, Henry LR, Carey LA, Brewer NT. Engaging in well being behaviors to decrease threat for breast cancer recurrence. Plos 1. 2013;eight(1):e53607.23. Stacey FG, James EL, Chapman K, Courneya KS, Lubans DR. A systematic critique and meta-analysis of social cognitive theory-based physical activity and/or nutrition behavior modify interventions for cancer survivors. J Cancer Surviv. 2014. Epub ahead of print. 24. Bluethmann SM, Vernon SW, Gabriel KP, Murphy CC, Bartholomew LK. Taking the subsequent step: a systematic assessment and meta-analysis of physical activity and behavior transform interventions in recent [https://dx.doi.org/10.3389/fpsyg.2013.00735 title= fpsyg.2013.00735] post-treatment breast cancer survivors. Breast Cancer Res Treat. 2015;149(two):331?2. 25. Matthews CE, Wilcox S, Hanby CL, Der Ananian C, Heiney SP, Gebretsadik T, Shintani A. Evaluation of a 12-week home-based walking intervention for breast cancer survivors. Assistance Care Cancer. 2007;15(2):203?1. 26. Pinto BM, Rabin C, Dunsiger S. Home-based workout among cancer survivors: adherence and its predictors. Psychooncology. 2009;18(four):369?6. 27. Spark LC, Reeves MM, Fjeldsoe BS, Eakin EG.Lu W, Nechuta SJ, Cadmus-Bertram L, Patterson RE, Sternfeld B et al. Meeting the physical activity recommendations and survival immediately after breast [https://dx.doi.org/10.1136/bcr-2013-202552 title= bcr-2013-202552] cancer: findings in the just after breast cancer pooling project. Breast Cancer Res Treat. 2012;131(2):637?3. Chen X, Zheng Y, Zheng W, Gu K, Chen Z, Lu W, Shu XO. The impact of standard exercising on high quality of life among breast cancer survivors. Am J Epidemiol. 2009;170(7):854?two. Irwin ML, McTiernan A, Manson JE, Thomson CA, Sternfeld B, Stefanick ML, Wactawski-Wende J, Craft L, Lane D, Martin LW et al. Physical activity and survival in postmenopausal girls with breast cancer: outcomes in the women's overall health initiative. Cancer Prev Res (Phila). 2011;4(four):522?. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic evaluation. J Natl Cancer Inst. 2012;104(11):815?0. Blanchard CM, Courneya KS, Stein K. Cancer survivors' adherence to way of life behavior recommendations and associations with health-related top quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol.

Lu W, Nechuta SJ, Cadmus-Bertram L, Patterson RE, Sternfeld B et

2018-01-12T10:12:38Z

Twig24helen:

Emery CF, Yang HC, Frierson GM, Peterson LJ, Suh S. Determinants of physical activity among females treated for breast cancer within a 5-year longitudinal follow-up investigation. Psychooncology. 2009;18(four):377?six. Silber JH, [https://dx.doi.org/10.3121/cmr.2012.1100.ps1-07 title= cmr.2012.1100.ps1-07] Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, Wang M, Niknam BA, Ludwig JM, Wang W et al. Qualities connected with differences in survival amongst black and white women with breast cancer. JAMA. 2013;310(4):389?7. Paxton RJ, Phillips KL, Jones LA, Chang S, Taylor WC, Courneya KS, Pierce JP. Associations among physical activity, physique mass index, and health-related excellent of life by race/ethnicity within a diverse sample of breast cancer survivors. Cancer. 2012;118(16):4024?1. Brawley OW. Wellness disparities in breast cancer. Obstet Gynecol Clin North Am. 2013;40(3):513?3. O'Neill SC, DeFrank JT, Vegella P, [http://kfyst.com/comment/html/?248040.html Or. This data was obtained by asking questions in regards to the factors] Richman AR, Henry LR, Carey LA, Brewer NT. Engaging in well being behaviors to lower danger for breast cancer recurrence. Plos A single. 2013;8(1):e53607.23. Stacey FG, James EL, Chapman K, Courneya KS, Lubans DR. A systematic overview and meta-analysis of social cognitive theory-based physical activity and/or nutrition behavior adjust interventions for cancer survivors. J Cancer Surviv. 2014. Epub ahead of print. 24. Bluethmann SM, Vernon SW, Gabriel KP, Murphy CC, Bartholomew LK. Taking the subsequent step: a systematic review and meta-analysis of physical activity and behavior adjust interventions in current [https://dx.doi.org/10.3389/fpsyg.2013.00735 title= fpsyg.2013.00735] post-treatment breast cancer survivors. Breast Cancer Res Treat. 2015;149(two):331?2. 25. Matthews CE, Wilcox S, Hanby CL, Der Ananian C, Heiney SP, Gebretsadik T, Shintani A. Evaluation of a 12-week home-based walking intervention for breast cancer survivors. Help Care Cancer. 2007;15(2):203?1. 26. Pinto BM, Rabin C, Dunsiger S. Home-based physical exercise amongst cancer survivors: adherence and its predictors. Psychooncology. 2009;18(4):369?six. 27.Lu W, Nechuta SJ, Cadmus-Bertram L, Patterson RE, Sternfeld B et al. Meeting the physical activity suggestions and survival after breast [https://dx.doi.org/10.1136/bcr-2013-202552 title= bcr-2013-202552] cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat. 2012;131(2):637?3. Chen X, Zheng Y, Zheng W, Gu K, Chen Z, Lu W, Shu XO. The effect of typical exercising on high quality of life amongst breast cancer survivors. Am J Epidemiol. 2009;170(7):854?two. Irwin ML, McTiernan A, Manson JE, Thomson CA, Sternfeld B, Stefanick ML, Wactawski-Wende J, Craft L, Lane D, Martin LW et al. Physical activity and survival in postmenopausal females with breast cancer: final results from the women's well being initiative. Cancer Prev Res (Phila). 2011;four(four):522?. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physical activity, biomarkers, and illness outcomes in cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104(11):815?0. Blanchard CM, Courneya KS, Stein K. Cancer survivors' adherence to lifestyle behavior suggestions and associations with health-related good quality of life: outcomes in the American Cancer Society's SCS-II. J Clin Oncol. 2008; 26(13):2198?04. Lynch BM, Dunstan DW, Healy GN, Winkler E, Eakin E, Owen N.

Can hinder achievement of optimal blood concentrations of antiTB drugs in

2018-01-11T08:05:36Z

Twig24helen:

Some patientsSu (2002) Gravendeel (2003) [http://ques2ans.gatentry.com/index.php?qa=103647&qa_1=atedexperimenteffect-sizes-cohens-sample-and-independent AtedExperimentEffect sizes are Cohen's d for 1 sample and independent] Bartacek (2009) Lienhardt (2011)0.16 [ ?.02 , 1.34 ] 0.70 [ ?.82 , 3.21 ] 1.63 [ ?.54 , 3.80 ] ?.20 [ ?.29 , ?.12 ]FE Model0.05 [ ?.82 , 0.92 ]?.?.2.Log Odds RatioFig. four ?Forest plot for default.b r a z i l i a n j o u r n a l o f m i c r o b i o l o g y 4 8 (2 0 1 7) 198?reported stopping medication mainly because of AEs,28 whereas other people indicated that they weren't informed about side effects or what to complete to counter them.29?1 No ophthalmic AEs (ocular toxic effects) have been reported that might be linked with the new drug (EMB). Retrobulbar optic neuritis, the key AE to EMB, is rare in the doses and exposure times frequently employed for TB remedy.32 Despite the prospective for giving the highest amount of evidence in therapeutic intervention research, RCTs happen to be criticized mainly because of their restricted generalizability. RCTs are often conducted under optimal health-related care and may perhaps underestimate the possible [https://dx.doi.org/10.1093/tropej/fmv055 title= tropej/fmv055] advantage of using 4-FDC formulations to boost adherence in settings exactly where malpractice or unmonitored therapies are frequent. Critical variations in adherence happen to be identified in several RCTs.33 Consequently, pragmatic clinical trials, which are carried out in a way that much more closely resembles common clinical practice, could possibly be far more suitable to receive a much better estimate of treatment effectiveness.34,35 In the beginning of 2013, a systematic assessment was published in Canada to evaluate the threat of therapy failure or illness relapse, acquired drug resistance, bacterial conversion immediately after two months of therapy, AEs, adherence, and therapy satisfaction related with treatment of active TB employing FDC or SD formulations.36 This study concluded that, although FDC formulations simplify TB therapy, the current proof did not indicate that these formulations boost treatment outcomes among sufferers with active TB. Nonetheless, that systematic overview integrated research of each four-drug and two-drug combinations and, consequently, differs in the present one inside the variety of retrieved articles. These differences justify the want for any revision to compare precisely the impact of 4-FDC versus SD [https://dx.doi.org/10.4103/2152-7806.162550 title= 2152-7806.162550] formulations. The World Wellness Organization has advised 4-FDC treatments since 1999. Combined treatment options prevent drug selection by the patient (monotherapy) by supplying all of the drugs inside the similar tablet.12,34,35,37 As a consequence of their simplified and standardized nature, 4-FDC regimens facilitate dosage calculation and protect against prescription errors. Having said that, certainly one of essentially the most relevant capabilities of 4-FDC formulations, the prevention of drug resistance, was not addressed in those research. Nonetheless, primarily based on their related efficacies, user-friendliness, decrease charges, and operational and logistical advantages, generalized use of 4-FDC formulations need to continue to be recommended. One particular [http://s154.dzzj001.com/comment/html/?174908.html 285 [0.0121] 0.0473*** [0.0211] 0.0116 [0.0171] 0.0217** [0.0311] 0.0550** [0.0355] 0.0359 [0.0154] 0.0093** [0.0096] 0.0573*** [0.0085] 0.0340** [0.0233] 0.0335 [0.0252] -0.0048 [0.0047] 0.0329** [0.0196] [0.0146] [0.0250] [0.0281] [0.0142] 0.0547*** 0.0654*** 0.0723* [0.0129] 0.0097** [0.0144] 0.0126*** [0.0392] 0.0067 [0.0046] 0.0429*** [0.0048] 0.0507*** [0.0110] 0.0731* [0.0117] 0.0535*** [0.0133] 0.0739*** [0.0388] 0.1120** [0.0152] 0.0121* [0.0064] 0.0398*** [0.0135] [0.0152] [0.0547] 0.0156 0.0035 0.0091 0.0100 0.0158 -0.0341 [0.0218] -0.0058 [0.0219] -0.0077** [0.0238] -0.0070* [0.0036] 0.0437* [0.0035] 0.0326 [0.0040] 0.0383 [0.0262] 0.0161 [0.0253] 0.0086 [0.0282] 0.0205 [0.0316] [0.0352] [0.0357] [0.0212] -0.0078 [0.0240] -0.0099* [0.0049] 0.0416* [0.0239] [0.0231] [0.0268] [0.0216] -0.0108** [0.0051] 0.0362 [0.0056] 0.0493* SE Use of] limitation of this meta-analysis is the fact that the included research didn't investigate adherence to the prescribed treatment.

Can hinder achievement of optimal blood concentrations of antiTB drugs in

2018-01-10T00:34:41Z

Twig24helen:

Moreover, the [https://dx.doi.org/10.1155/2013/480630 title= 2013/480630] influence of your Straight Observed Therapy Short-Course (DOTS) method around the outcomes of TB treatment was not assessed, which resulted in significantly less precise estimates.Can hinder achievement of optimal blood concentrations of antiTB drugs in patients co-infected with HIV.27 This observation suggests that 4-FDC therapy, by causing fewer gastrointestinal unwanted effects, would benefit co-infected patients. Some patientsSu (2002) Gravendeel (2003) Bartacek (2009) Lienhardt (2011)0.16 [ ?.02 , 1.34 ] 0.70 [ ?.82 , 3.21 ] 1.63 [ ?.54 , 3.80 ] ?.20 [ ?.29 , ?.12 ]FE Model0.05 [ ?.82 , 0.92 ]?.?.2.Log Odds RatioFig. four ?Forest plot for default.b r a z i l i a n j o u r n a l o f m i c r o b i o l o g y four 8 (2 0 1 7) 198?reported stopping medication simply because of AEs,28 whereas other individuals indicated that they weren't informed about unwanted effects or what to complete to counter them.29?1 No ophthalmic AEs (ocular toxic effects) had been reported that could be associated with all the new drug (EMB). Retrobulbar optic neuritis, the key AE to EMB, is uncommon in the doses and exposure times commonly used for TB treatment.32 In spite of the prospective for providing the highest degree of proof in therapeutic intervention investigation, RCTs have been criticized because of their limited generalizability. RCTs are normally performed beneath optimal healthcare care and may possibly underestimate the potential [https://dx.doi.org/10.1093/tropej/fmv055 title= tropej/fmv055] advantage of making use of 4-FDC formulations to enhance adherence in settings exactly where malpractice or unmonitored therapies are typical. Crucial differences in adherence have been located in lots of RCTs.33 As a result, pragmatic clinical trials, that are carried out inside a way that additional closely resembles typical clinical practice, can be more suitable to obtain a better estimate of remedy effectiveness.34,35 At the beginning of 2013, a systematic overview was published in Canada to evaluate the danger of therapy failure or illness relapse, acquired drug resistance, bacterial conversion soon after two months of treatment, AEs, adherence, and treatment satisfaction connected with therapy of active TB working with FDC or SD formulations.36 This study concluded that, even though FDC formulations simplify TB therapy, the existing evidence didn't indicate that these formulations boost therapy outcomes amongst patients with active TB. Having said that, that systematic assessment integrated studies of both four-drug and two-drug combinations and, as a result, differs from the present one in the variety of retrieved articles. These differences justify the have to have for a revision to evaluate precisely the effect of 4-FDC versus SD [https://dx.doi.org/10.4103/2152-7806.162550 title= 2152-7806.162550] formulations. The World Wellness Organization has suggested 4-FDC therapies [http://www.musicpella.com/members/output09sing/activity/529603/ T al. The Anatomical Society core regional anatomy syllabus for undergraduate] considering that 1999. Combined remedies stop drug choice by the patient (monotherapy) by offering all of the drugs within the very same tablet.12,34,35,37 As a result of their simplified and standardized nature, 4-FDC regimens facilitate dosage calculation and avoid prescription errors. Nevertheless, among essentially the most relevant options of 4-FDC formulations, the prevention of drug resistance, was not addressed in those studies. Nevertheless, based on their similar efficacies, user-friendliness, lower fees, and operational and logistical benefits, generalized use of 4-FDC formulations must continue to be advisable. A single limitation of this meta-analysis is that the integrated research did not investigate adherence for the prescribed treatment.